Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.43T | 1.36T | 1.16T | 1.19T | 1.05T | Gross Profit |
2.36T | 1.36T | 1.16T | 1.19T | 1.05T | EBIT |
1.07T | 344.63B | 257.84B | 202.20B | 110.50B | EBITDA |
623.70B | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
442.56B | 340.37B | 251.10B | 183.84B | 95.66B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.55T | 764.89B | 807.23B | 1.08T | 1.03T | Total Assets |
23.64T | 19.58T | 17.53T | 15.74T | 13.77T | Total Debt |
2.01T | 1.89T | 1.62T | 1.44T | 2.14T | Net Debt |
108.69B | 526.05B | -215.23B | -36.71B | 859.99B | Total Liabilities |
20.94T | 17.37T | 15.65T | 14.07T | 12.48T | Stockholders Equity |
2.56T | 2.14T | 1.82T | 1.58T | 1.23T |
Cash Flow | Free Cash Flow | |||
1.54T | -62.39B | 562.51B | 1.36T | 776.91B | Operating Cash Flow |
1.57T | -37.71B | 581.11B | 1.38T | 795.65B | Investing Cash Flow |
-1.46T | -680.05B | -393.21B | -629.87B | -423.08B | Financing Cash Flow |
137.65B | 247.91B | 174.51B | -546.67B | 29.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $119.54B | 19.57 | 17.89% | 0.61% | 22.15% | 12.13% | |
76 Outperform | $62.35B | 9.65 | 20.84% | 5.65% | -7.01% | 15.18% | |
76 Outperform | $58.73B | 12.32 | 9.95% | 3.66% | 36.29% | -19.79% | |
73 Outperform | $172.51B | 21.81 | 14.51% | 0.82% | 13.13% | 0.54% | |
70 Outperform | $23.73B | 7.93 | 10.44% | 1.25% | -8.55% | 13.58% | |
70 Outperform | $18.73B | 15.10 | 11.61% | 4.41% | -3.94% | 31.52% | |
63 Neutral | $12.37B | 9.56 | 7.95% | 79.17% | 12.62% | -5.26% |